Literature DB >> 32467620

The changing landscape of cancer in the USA - opportunities for advancing prevention and treatment.

Farhad Islami1, Rebecca L Siegel2, Ahmedin Jemal2.   

Abstract

The cancer landscape of the USA is continually evolving owing to changing risk factor patterns and disease classifications, improvements in detection and treatment, and demographic changes, such as ageing and population growth. Monitoring the burden of cancer, including incidence and mortality, is a key tool for assessing progress, identifying emerging trends and setting priorities to reduce the burden. In this Perspective, we describe trends in cancer incidence and mortality in the USA overall, and for major cancer types, and describe the main contributing factors, including risk factors, screening, treatment and access to care. When relevant, we provide information based on sex and common classifications of race/ethnicity, socioeconomic status and geographical region. We then discuss the implications of the patterns of cancer incidence and mortality for cancer research, prevention and care.

Entities:  

Mesh:

Year:  2020        PMID: 32467620     DOI: 10.1038/s41571-020-0378-y

Source DB:  PubMed          Journal:  Nat Rev Clin Oncol        ISSN: 1759-4774            Impact factor:   66.675


  127 in total

1.  Poverty, culture, and social injustice: determinants of cancer disparities.

Authors:  Harold P Freeman
Journal:  CA Cancer J Clin       Date:  2004 Mar-Apr       Impact factor: 508.702

2.  Factors That Contribute to Differences in Survival of Black vs White Patients With Colorectal Cancer.

Authors:  Helmneh M Sineshaw; Kimmie Ng; W Dana Flanders; Otis W Brawley; Ahmedin Jemal
Journal:  Gastroenterology       Date:  2017-11-14       Impact factor: 22.682

3.  The history and use of cancer registry data by public health cancer control programs in the United States.

Authors:  Mary C White; Frances Babcock; Nikki S Hayes; Angela B Mariotto; Faye L Wong; Betsy A Kohler; Hannah K Weir
Journal:  Cancer       Date:  2017-12-15       Impact factor: 6.860

4.  Deaths: Final Data for 2017.

Authors:  Kenneth D Kochanek; Sherry L Murphy; Jiaquan Xu; Elizabeth Arias
Journal:  Natl Vital Stat Rep       Date:  2019-06

Review 5.  A perfect storm: How tumor biology, genomics, and health care delivery patterns collide to create a racial survival disparity in breast cancer and proposed interventions for change.

Authors:  Bobby Daly; Olufunmilayo I Olopade
Journal:  CA Cancer J Clin       Date:  2015-04-09       Impact factor: 508.702

6.  Cancer statistics, 2020.

Authors:  Rebecca L Siegel; Kimberly D Miller; Ahmedin Jemal
Journal:  CA Cancer J Clin       Date:  2020-01-08       Impact factor: 508.702

7.  Potentially preventable premature lung cancer deaths in the USA if overall population rates were reduced to those of educated whites in lower-risk states.

Authors:  Farhad Islami; Elizabeth M Ward; Eric J Jacobs; Jiemin Ma; Ann Goding Sauer; Joannie Lortet-Tieulent; Ahmedin Jemal
Journal:  Cancer Causes Control       Date:  2015-01-03       Impact factor: 2.506

8.  Trends and Patterns of Disparities in Cancer Mortality Among US Counties, 1980-2014.

Authors:  Ali H Mokdad; Laura Dwyer-Lindgren; Christina Fitzmaurice; Rebecca W Stubbs; Amelia Bertozzi-Villa; Chloe Morozoff; Raghid Charara; Christine Allen; Mohsen Naghavi; Christopher J L Murray
Journal:  JAMA       Date:  2017-01-24       Impact factor: 56.272

9.  Cancer statistics, 1995.

Authors:  P A Wingo; T Tong; S Bolden
Journal:  CA Cancer J Clin       Date:  1995 Jan-Feb       Impact factor: 508.702

10.  Annual Report to the Nation on the Status of Cancer, part I: National cancer statistics.

Authors:  Kathleen A Cronin; Andrew J Lake; Susan Scott; Recinda L Sherman; Anne-Michelle Noone; Nadia Howlader; S Jane Henley; Robert N Anderson; Albert U Firth; Jiemin Ma; Betsy A Kohler; Ahmedin Jemal
Journal:  Cancer       Date:  2018-05-22       Impact factor: 6.860

View more
  8 in total

1.  Improving the detection of aggressive prostate cancer using immunohistochemical staining of protein marker panels.

Authors:  Qing Kay Li; Tung-Shing Mamie Lih; Yuefan Wang; Yingwei Hu; Naseruddin Höti; Daniel W Chan; Hui Zhang
Journal:  Am J Cancer Res       Date:  2022-03-15       Impact factor: 6.166

2.  Cancer mortality in Italian populations: differences between Italy and the USA.

Authors:  Claudia Santucci; Heidy N Medina; Greta Carioli; Eva Negri; Carlo La Vecchia; Paulo S Pinheiro
Journal:  Eur J Cancer Prev       Date:  2021-08-26       Impact factor: 2.164

3.  The Association Between Vitamin C and Cancer: A Two-Sample Mendelian Randomization Study.

Authors:  Hanxiao Chen; Ze Du; Yaoyao Zhang; Mengling Li; Rui Gao; Lang Qin; Hongjing Wang
Journal:  Front Genet       Date:  2022-05-05       Impact factor: 4.772

Review 4.  Non-Steroidal Anti-Inflammatory Drugs in Colorectal Cancer Chemoprevention.

Authors:  Jadwiga Maniewska; Dagmara Jeżewska
Journal:  Cancers (Basel)       Date:  2021-02-03       Impact factor: 6.639

5.  Synthesis, Characterization, and Antiproliferative Activity of Novel Chiral [QuinoxP*AuCl2]+ Complexes.

Authors:  Adedamola S Arojojoye; R Tyler Mertens; Samuel Ofori; Sean R Parkin; Samuel G Awuah
Journal:  Molecules       Date:  2020-12-04       Impact factor: 4.411

Review 6.  Role of long noncoding RNA taurine-upregulated gene 1 in cancers.

Authors:  Miao Da; Jing Zhuang; Yani Zhou; Quan Qi; Shuwen Han
Journal:  Mol Med       Date:  2021-05-26       Impact factor: 6.354

7.  Proteomic characterization of primary and metastatic prostate cancer reveals reduced proteinase activity in aggressive tumors.

Authors:  Qing Kay Li; Jing Chen; Yingwei Hu; Naseruddin Höti; Tung-Shing Mamie Lih; Stefani N Thomas; Li Chen; Sujayita Roy; Alan Meeker; Punit Shah; Lijun Chen; G Steven Bova; Bai Zhang; Hui Zhang
Journal:  Sci Rep       Date:  2021-09-23       Impact factor: 4.379

Review 8.  Health inequity drives disease biology to create disparities in prostate cancer outcomes.

Authors:  William G Nelson; Otis W Brawley; William B Isaacs; Elizabeth A Platz; Srinivasan Yegnasubramanian; Karen S Sfanos; Tamara L Lotan; Angelo M De Marzo
Journal:  J Clin Invest       Date:  2022-02-01       Impact factor: 14.808

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.